2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease

M. Salari, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington´s disease – A case report

T.T.C. Capato, R.G. Cury, R. Gimaães, E.T. Fonoff, M.S. Haddad (São Paulo, Brazil)

Surgical therapy: Other movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Fundamental differences in Parkinsonian rat limbic regions contribute to anxious behavior and diminished responsiveness to diazepam

K.A. O'Connor, P.J. Feustel, A. Ramirez-Zamora, E. Molho, J.G. Pilitsis, D.S. Shin (Albany, NY, USA)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Gastrointestinal non-motor symptoms in PD: Correlation between objective markers and subjective symptoms

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus C., Denmark)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Gender differences in heart rate variability among patients affected by Parkinson’s disease

P. Solla, E. Erriu, C. Cadeddu, L. Cugusi, G. Costantini, S. Nieddu, M.R. Aresu, R. Farris, M. Meloni, D. Fonti, G. Mercuro, F. Marrosu (Monserrato (Cagliari), Italy)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Generation and characterization of iPSC-derived nigral dopaminergic and pyramidal glutamatergic neurons from patients affected by multiple system atrophy

G. Monzio Compagnoni, E. Frattini, S. Salani, F. Fortunato, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milan, Italy)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Genetic risk of Parkinson’s disease in the general population

S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Glucagon-like peptide 1 analogues for treating multiple system atrophy: A translational study

F. Bassil, M.H. Canron, A. Vital, E. Bezard, Y. Li, N.H. Greig, P.O. Fernagut, W.G. Meissner (Bordeaux, France)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2